When Does the Meloxicam Patent Expire?
The primary patent covering meloxicam, U.S. Patent No. 4,233,452, expired on August 16, 2005 [1]. However, multiple other patents have been issued relating to meloxicam, covering aspects such as formulations and methods of use [2]. These later patents may influence market exclusivity for specific meloxicam products or applications.
What Other Patents Exist for Meloxicam?
Beyond the foundational patent, numerous other patents have been granted for meloxicam. For instance, U.S. Patent No. 6,479,517 relates to a specific orally disintegrating tablet formulation of meloxicam [3]. U.S. Patent No. 6,750,257, expired on August 11, 2020, covered a method for treating osteoarthritis with meloxicam [4]. A review of patent databases, such as DrugPatentWatch.com, can provide comprehensive details on the full spectrum of meloxicam-related patents and their expiration dates [1].
Can Generic Meloxicam Be Sold Before Patent Expiry?
Generally, generic versions of a drug cannot be marketed until all relevant patents have expired or have been successfully challenged. The expiration of the main composition-of-matter patent in 2005 allowed for generic competition for the original meloxicam formulations [1]. However, the existence of later patents for specific formulations or uses could potentially limit the market entry of certain generic versions until those patents expire [3, 4].
Who Makes Generic Meloxicam?
A significant number of pharmaceutical companies manufacture and market generic versions of meloxicam. This includes major generic drug producers. The availability of generic meloxicam is widespread across pharmacies in many countries.
How Does Meloxicam Work?
Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting cyclooxygenase (COX) enzymes, specifically COX-2, to a greater extent than COX-1 [5]. This inhibition reduces the production of prostaglandins, which are mediators of inflammation, pain, and fever [5]. This mechanism is common to most NSAIDs, though the selective inhibition of COX-2 is intended to reduce gastrointestinal side effects associated with older, non-selective NSAIDs [5].
What is Meloxicam Used For?
Meloxicam is primarily prescribed to relieve the symptoms of osteoarthritis and rheumatoid arthritis [5]. It is used to reduce pain, swelling, and stiffness in affected joints. It may also be used for other inflammatory conditions where pain relief is needed.
What Are the Risks or Side Effects of Meloxicam?
Like other NSAIDs, meloxicam carries potential risks and side effects. These can include gastrointestinal problems such as stomach ulcers and bleeding, cardiovascular events like heart attack and stroke, and kidney problems [5]. Patients should discuss these risks with their healthcare provider, especially if they have pre-existing conditions.
---
Sources
[1] DrugPatentWatch.com
[2] DrugPatentWatch.com
[3] DrugPatentWatch.com
[4] DrugPatentWatch.com
[5] National Institutes of Health (NIH)